ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ravi Madan discussing preliminary data from 6 month follow-up assessing prospective monitoring of PSMA–positive ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment. A new Phase 2 clinical ...

Patients with prostate cancer may have a lower risk of recurrence if they take multivitamin supplements after diagnosis, new data suggest.

Prostate cancer, one of the most common cancers among men, has come under renewed focus amid rising cases globally and in ...

Understanding causes of death among men with prostate cancer recurrence after localized treatment is essential for informed decision-making.

New research suggests that men who take multivitamins after being diagnosed with prostate cancer may have a lower risk of ...

A team of Swedish researchers has discovered that a drug traditionally meant for type 2 diabetes shows promise in keeping prostate cancer at bay.

Discover a recent study that has identified a gene that plays a role in prostate cancer susceptibility. Learn more.

Older diabetes medications known as thiazolidinediones (TZDs) may slow prostate cancer progression, new research indicates.